We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Targeting HER2 Across Advanced Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
Brad McGregor, MD
Kathleen Moore, MD, MS
Shubham Pant, MD, MBBS
Addressing the Unmet Need in HER2-Positive Advanced Solid Tumors: Exploring Response Rates and Duration of Response
Targeting HER2 in Advanced Solid Tumors: A Comprehensive Understanding of the Rationale and Potential Benefits
Testing for Solid Tumors: Tissue and Liquid Biopsy Approaches Using NGS Technologies for cfDNA and ctDNA Analysis
Management Strategies for Treatment-Emergent Adverse Events (TEAEs) in HER2-Altered Advanced Solid Tumors
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
Ovarian Cancer: Advances in HER2-Targeted ADCs
Endometrial Cancer: HER2-Targeted ADCs: A Promising Approach to Address Unmet Needs
Biliary Tract and Pancreatic Cancer: HER2-Targeted ADCs for Gastrointestinal Cancers
Bladder Cancer: HER2-Targeted ADCs for Genitourinary Cancers
ASCO/ESMO 2023 Roundtable: Contextualizing the Latest Advances in HER2-Targeted Therapy for Solid Tumors
Postpartum Depression: A Significant Burden and a Novel Approach to Treatment
Lee Shulman MD, FACOG, FACMG
Kristina Deligiannidis, MD
Migraine and Women's Health: Migraine and the Whole Female Patient
Jessica Ailani, MD
Dawn C. Buse, PhD
Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation
Cara Dolin, MD
Jennifer Simpson
Diana Girnita, MD ,PhD
Hot Topics in Blood-based Cancer Screening: Key Information on Multi-Cancer Early Detection from 2023 Spring Oncology Meetings
Candace T. Westgate, DO, MPH, FACOG
Ethan D. Schram, MD, FACP
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education